🌎 CRH Initiated, Repligen Initiated, RB Global Initiated and more…

🌎 CRH Initiated, Repligen Initiated, RB Global Initiated and…

June 18, 2024
by RJ Hamster

VIEW MY PORTFOLIO

June 18th, 2024

How Biden has already won 2024 (ad)

Obama’s Forever Term [Exposed] or Obama Biden has already won 2024

Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.

Click here to watch this now before it’s too late.

Today’s Top Stories

Occidental Stock: Buffett’s 9-Day Buying Spree Lifts Stake to 29%

McDonald’s is ending its test run of AI-powered drive-thrus with IBM

Elon Musk’s Final Masterpiece: “X-9840” (Paradigm Press)

3M Stock: Invest Now for Unmatched Quality and Growth Potential

Sprint great Michael Johnson launching ‘Grand Slam Track’ league with $100K first prizes

Super Micro AI Stock: Should You Invest After a 275% Increase?

Adidas is investigating allegations of embezzlement and bribery in China, according to news reports

Fed’s Plan to Control American Bank Accounts (Weiss Ratings)

VinFast Auto’s EV Sales Target: Stock Market Hype or Reality?

Ecuador stops waiving visas for Chinese nationals because of an increase in irregular migration

Beyond Meat Forecast: Is There Any Hope Left for This Stock?

Ecuador suspends an agreement with China waiving visas for Chinese nationals, citing an increase in irregular migration

Quick Links

MarketBeat All Access

Must-See: Elon’s New Invention is Absolutely Insane (ad)

image for Must-See: Elon’s New Invention is Absolutely Insane

Could Elon’s New Device be Bigger than the iPhone?

According to 30-year Silicon Valley and Wall Street veteran, Eric Fry…

This mind-blowing new technology could be bigger than the iPhone.

Click here for the full story…

Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)

Apple Inc. (AAPL)
- Apple (NASDAQ:AAPL) had its price target raised by analysts at JPMorgan Chase & Co. ( ) from $225.00 to $245.00. They now have an “overweight” rating on the stock. This represents a 14.4% upside from the current price of $214.22.
- Apple was the recipient of unusually large options trading activity on Monday. Stock traders bought 1,423,490 call options on the company. This is an increase of approximately 28% compared to the typical volume of 1,110,504 call options.
- (6/18) Apple Stock Falls Despite New Price Target. It’s Among the Highest on Wall Street. (barrons.com)
- (6/18) Apple (NASDAQ:AAPL) Price Target Increased to $245.00 by Analysts at JPMorgan Chase & Co.(marketbeat.com)
- (6/18) Addigy Wins Awards for Best Apple Device Management and Inc. Best Workplace (businesswire.com)
- (6/18) Hart & Patterson Financial Group LLC Takes Position in Apple Inc. (NASDAQ:AAPL) (marketbeat.com)
- (6/18) Did Apple Just Become the AI Stock to Beat? (fool.com)
- (6/18) Forget Nvidia: Why Apple’s AI Bombshell Could Trigger a 50% Surge in AAPL Stock (investorplace.com)
- (6/18) Apple Pay Later is dead, long live Affirm loans – Engadget (news.google.com)
- (6/18) Apple Scraps Its Buy Now, Pay Later Product. Forget Payments, AI Is the Focus. (barrons.com)
- (6/18) 6 Reasons the S&P 500 Will Keep Rising This Year (AAPL) (marketbeat.com)
- (6/18) Bubble Trouble: 3 Stocks Ready to Burst Under the Weight of Their Own Hype (investorplace.com)
Amazon.com, Inc. (AMZN)
Alphabet Inc. (GOOGL)
Meta Platforms, Inc. (META)
- CEO Mark Zuckerberg sold 16,702 shares of Meta Platforms stock in a transaction on Friday, June 14th. The shares were sold at an average price of $503.34, for a total transaction of $8,406,784.68. Following the transaction, the chief executive officer now owns 275,297 shares in the company, valued at approximately $138,567,991.98. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
- COO Javier Olivan sold 412 shares of Meta Platforms stock in a transaction on Thursday, June 13th. The shares were sold at an average price of $505.75, for a total transaction of $208,369.00. Following the transaction, the chief operating officer now owns 8,031 shares in the company, valued at approximately $4,061,678.25. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
- (6/18) 2 AI Stocks To Watch In June 2024 (stockmarket.com)
- (6/18) AI-Driven Growth, Strategic Investments Propel Meta Platforms’ Potential (gurufocus.com)
- (6/18) B. Riley Wealth Advisors Inc. Sells 6,300 Shares of Meta Platforms, Inc. (NASDAQ:META) (marketbeat.com)
- (6/18) 3 Dividend Dynamos to Turbocharge Your Income Stream for Life (investorplace.com)
- (6/18) 3 Magnificent 7 Stocks to Buy Now: June 2024 (investorplace.com)
- (6/18) 3 Low-Debt Stocks Delivering High Returns (investorplace.com)
- (6/18) Insider Selling: Meta Platforms, Inc. (NASDAQ:META) COO Sells 412 Shares of Stock (insidertrades.com)
- (6/17) Accent Capital Management LLC Makes New Investment in Meta Platforms, Inc. (NASDAQ:META)(marketbeat.com)
- (6/17) Javier Olivan Sells 412 Shares of Meta Platforms, Inc. (NASDAQ:META) Stock (marketbeat.com)
- (6/17) S&P 500 Boosted Stock Buybacks by 10% in Q1 (investopedia.com)
Microsoft Co. (MSFT)

Analysts’ Upgrades

Juniper Networks (NYSE:JNPR) was upgraded by analysts at Argus from a “hold” rating to a “buy” rating. They now have a $40.00 price target on the stock. This represents a 12.6% upside from the current price of $35.51.
Kroger (NYSE:KR) was upgraded by analysts at BMO Capital Markets from a “market perform” rating to an “outperform” rating. They now have a $60.00 price target on the stock, up previously from $58.00. This represents a 15.5% upside from the current price of $51.93.
QuinStreet (NASDAQ:QNST) was upgraded by analysts at Craig Hallum from a “hold” rating to a “buy” rating. They now have a $22.00 price target on the stock. This represents a 31.1% upside from the current price of $16.78.
STMicroelectronics (NYSE:STM) was upgraded by analysts at The Goldman Sachs Group, Inc. from a “sell” rating to a “neutral” rating. They now have a $45.80 price target on the stock, up previously from $35.50. This represents a 6.3% upside from the current price of $43.10.
Sunoco (NYSE:SUN) was upgraded by analysts at Citigroup Inc. from a “neutral” rating to a “buy” rating. They now have a $65.00 price target on the stock. This represents a 18.1% upside from the current price of $55.02.
View today’s most recent analysts’ upgrades at MarketBeat.com

Write this ticker symbol down… (ad)

A megatrend now poised to mint a brand-new wave of millionaires right here in America.

And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.

Discover the #1 company leading this revolution

Analysts’ Downgrades

Aerovate Therapeutics (NASDAQ:AVTE) was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating. They now have a $2.00 price target on the stock, down previously from $35.00. This represents a 33.8% upside from the current price of $1.50.
Aerovate Therapeutics (NASDAQ:AVTE) was downgraded by analysts at TD Cowen from a “buy” rating to a “hold” rating.The current price is $1.50.
Aerovate Therapeutics (NASDAQ:AVTE) was downgraded by analysts at Evercore ISI from an “outperform” rating to an “inline” rating. They now have a $2.00 price target on the stock, down previously from $27.00. This represents a 33.8% upside from the current price of $1.50.
Equitable (NYSE:EQH) was downgraded by analysts at UBS Group AG from a “buy” rating to a “neutral” rating. They now have a $43.00 price target on the stock, up previously from $40.00. This represents a 7.6% upside from the current price of $39.95.
First Solar (NASDAQ:FSLR) was downgraded by analysts at Janney Montgomery Scott from a “buy” rating to a “neutral” rating.The current price is $261.25.
Ovid Therapeutics (NASDAQ:OVID) was downgraded by analysts at Oppenheimer Holdings Inc. from an “outperform” rating to a “market perform” rating.The current price is $0.84.
Zentalis Pharmaceuticals (NASDAQ:ZNTL) was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating.The current price is $5.51.
Zentalis Pharmaceuticals (NASDAQ:ZNTL) was downgraded by analysts at Wedbush from a “neutral” rating to an “underperform” rating. They now have a $4.00 price target on the stock, down previously from $15.00. This represents a 27.4% downside from the current price of $5.51.
View today’s most recent analysts’ downgrades at MarketBeat.com

AI’s Next Magnificent Seven (ad)

The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.

See His Breakdown of the Seven Stocks You Should Own Here.

Analysts’ New Coverage

Autoliv (NYSE:ALV) is now covered by analysts at BNP Paribas. They set a “neutral” rating on the stock.The current price is $109.49.
Amerant Bancorp (NASDAQ:AMTB) is now covered by analysts at Janney Montgomery Scott. They set a “buy” rating and a $25.00 price target on the stock. This represents a 16.6% upside from the current price of $21.44.
Cardlytics (NASDAQ:CDLX) is now covered by analysts at Northland Securities. They set an “outperform” rating and a $14.00 price target on the stock. This represents a 71.8% upside from the current price of $8.15.
Celldex Therapeutics (NASDAQ:CLDX) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $58.00 price target on the stock. This represents a 64.9% upside from the current price of $35.17.
CRH (NYSE:CRH) is now covered by analysts at Stephens. They set an “overweight” rating and a $95.00 price target on the stock. This represents a 22.1% upside from the current price of $77.83.
Innoviva (NASDAQ:INVA) is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating on the stock.The current price is $16.36.
Knife River (NYSE:KNF) is now covered by analysts at Stephens. They set an “overweight” rating and a $85.00 price target on the stock. This represents a 20.7% upside from the current price of $70.41.
Kopin (NASDAQ:KOPN) is now covered by analysts at Lake Street Capital. They set a “buy” rating and a $2.50 price target on the stock. This represents a 242.7% upside from the current price of $0.73.
Omega Therapeutics (NASDAQ:OMGA) is now covered by analysts at Raymond James. They set an “outperform” rating and a $12.00 price target on the stock. This represents a 476.9% upside from the current price of $2.08.
Pilgrim’s Pride (NASDAQ:PPC) is now covered by analysts at Argus. They set a “buy” rating and a $41.00 price target on the stock. This represents a 17.0% upside from the current price of $35.05.
Praxis Precision Medicines (NASDAQ:PRAX) is now covered by analysts at Guggenheim. They set a “buy” rating and a $155.00 price target on the stock. This represents a 297.4% upside from the current price of $39.00.
RB Global (NYSE:RBA) (TSE:RBA) is now covered by analysts at CIBC. They set a “sector outperform” rating on the stock.The current price is $81.25.
Repligen (NASDAQ:RGEN) is now covered by analysts at Guggenheim. They set a “neutral” rating on the stock.The current price is $123.04.
Sportradar Group (NASDAQ:SRAD) is now covered by analysts at JPMorgan Chase & Co.. They set a “neutral” rating and a $12.00 price target on the stock. This represents a 12.3% upside from the current price of $10.69.
TF Financial (NASDAQ:THRD) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $23.00 price target on the stock. This represents a 77.6% upside from the current price of $12.95.
View today’s most recent analysts’ new coverage at MarketBeat.com

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.

START YOUR 30-DAY FREE TRIAL

Calendars from MarketBeat

U.S. Analyst Ratings
Corporate Buybacks
Cryptocurrencies
Dividend Declarations
Earnings Announcements
Economic Reports
Gap Up/Down Stocks
Insider Trades
Initial Public Offerings (IPOs)
Most Active Stocks
Percentage Gainers/Decliners
Sector Performance
Short Interest
Unusual Options Volume
Unusual Trading Volume

Upgrade Your Subscription

Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET.

UPGRADE NOW

Manage Your Watchlist

View and add up to five holdings to your watchlist.

VIEW MY PORTFOLIO

Join Our Facebook Group

Join MarketBeat’s free stock discussion and trading idea group on Facebook.

JOIN NOW

Thank you for subscribing to MarketBeat!

We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that’s you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.

If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.

Today’s Bonus Content: 2024 Crypto Secrets (Click to Opt-in)

Amazon Just Made a $144 Million Investment in One Small AI Company

NYSE biotech company’s drug could be as revolutionary as penicillin!

RJ Hamster

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.